Rubicon Research

Rubicon develops high quality pharmaceutical products using innovative technology and non-infringing & cost effective processes which are scalable to manufacturing level with robust process parameters. Rubicon has developed several value added products for its partners especially in the area of -Life Cycle Management (LCM) Opportunities for Specialty Companies -Re-purposing existing drug compounds -Age Appropriate Dosage Form Development (Pediatric and Geriatric) Rubicon offers formulations considering the opportunity of life cycle management of the product. This is done using Rubicon’s proprietary technologies and optimization of various pharmacokinetic parameters desired for better therapeutic benefit. Many compounds are eliminated from the drug development pipeline due to poor solubility or bioavailability. With Rubicon’s expertise and capabilities, you can screen more number of candidates and improve the success rate of your discovery compounds moving to development stage. We offer solutions to your complex formulation challenges and also accelerate the process to reach the clinic and market faster.Founded in 1999, Rubicon operates out of three locations, Corporate HQ and R&D center based in Thane, India and USFDA & MHRA inspected manufacturing facility based out of Ambernath (Thane), India and a Marketing office in Plainsboro, (NJ), USA.